Opko Health (Israel) Performance
| OPK Stock | 587.50 5.30 0.89% |
Opko Health has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of -0.61, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Opko Health are expected to decrease at a much lower rate. During the bear market, Opko Health is likely to outperform the market. Opko Health right now holds a risk of 3.63%. Please check Opko Health sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Opko Health will be following its historical price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Opko Health are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong forward-looking signals, Opko Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 72.2 M | |
| Total Cashflows From Investing Activities | 35.9 M |
Opko |
Opko Health Relative Risk vs. Return Landscape
If you would invest 59,130 in Opko Health on August 25, 2024 and sell it today you would lose (380.00) from holding Opko Health or give up 0.64% of portfolio value over 90 days. Opko Health is generating 0.0504% of daily returns assuming 3.6315% volatility of returns over the 90 days investment horizon. Simply put, 32% of all stocks have less volatile historical return distribution than Opko Health, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Opko Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opko Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Opko Health, and traders can use it to determine the average amount a Opko Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0139
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | OPK | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.63 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Opko Health is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opko Health by adding it to a well-diversified portfolio.
Opko Health Fundamentals Growth
Opko Stock prices reflect investors' perceptions of the future prospects and financial health of Opko Health, and Opko Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Opko Stock performance.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.9 B | |||
| Shares Outstanding | 772.69 M | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 2.78 X | |||
| Revenue | 1.77 B | |||
| EBITDA | 35.8 M | |||
| Cash And Equivalents | 207.25 M | |||
| Cash Per Share | 0.34 X | |||
| Total Debt | 187.9 M | |||
| Debt To Equity | 20.50 % | |||
| Book Value Per Share | 2.11 X | |||
| Cash Flow From Operations | 38.34 M | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 2.4 B | |||
About Opko Health Performance
By analyzing Opko Health's fundamental ratios, stakeholders can gain valuable insights into Opko Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Opko Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Opko Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. OPKO HEALTH operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 5690 people.Things to note about Opko Health performance evaluation
Checking the ongoing alerts about Opko Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Opko Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Opko Health had very high historical volatility over the last 90 days | |
| The company reported the revenue of 1.77 B. Net Loss for the year was (30.14 M) with profit before overhead, payroll, taxes, and interest of 504.67 M. | |
| About 46.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Opko Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Opko Health's stock is overvalued or undervalued compared to its peers.
- Examining Opko Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Opko Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Opko Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Opko Health's stock. These opinions can provide insight into Opko Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Opko Stock analysis
When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |